Attached files
| file | filename |
|---|---|
| EX-31.2 - Vilacto Bio Inc. | ex31_2.htm |
| EX-31.1 - Vilacto Bio Inc. | ex31_1.htm |
| EX-10.1 - Vilacto Bio Inc. | ex10_1.htm |
| 10-K - Vilacto Bio Inc. | mainbody.htm |
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND
CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the annual Report of Vilacto Bio, Inc. (the “Company”) on Form 10-K for the year ended March 31, 2017 filed with the Securities and Exchange Commission (the “Report”), I, Gert Andersen, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented.
| By: | /s/ Gert Andersen |
| Name: | Gert Andersen |
| Title: | Principal Executive Officer, Principal Financial Officer and Director |
| Date: | July 14, 2017 |
This certification has been furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.